Lilly’s Affordable Zepbound Vials: A Game Changer
Eli Lilly launches affordable Zepbound vials, easing supply issues and competing with Novo Nordisk's weight-loss drug.
- Latest
- Trending
Eli Lilly launches affordable Zepbound vials, easing supply issues and competing with Novo Nordisk's weight-loss drug.
Quant analyst PlanB reaffirms Bitcoin's journey to $500k, driven by 200-week moving average insights.
A recent report reveals growing concerns among tech leaders over SaaS security, with 45% experiencing incidents in the past year.
Discover how XR offers training solutions to barriers, enabling career growth and addressing labor shortages.
Epic Systems introduces 100+ new AI features to enhance healthcare operations for doctors and patients.
GenScript Biotech sees 43.5% revenue rise, expanding global reach and strengthening pipeline.
Surgeons in Idaho use 3D holograms for precise surgery, enhancing outcomes.
Biotech firms restructure with layoffs as FDA approves new drugs, exemplifying industry challenges and opportunities.
Adaptimmune's Tecelra launch marks progress in cell therapy, with strong Q2 financials and strategic plans for cancer treatment.
Federal push to harness AI in medical research relies on extensive data collection and privacy safeguards.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.